Journal
NATURE REVIEWS NEUROSCIENCE
Volume 12, Issue 10, Pages 603-612Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/nrn3113
Keywords
-
Categories
Funding
- Leverhulme Trust
- UK Medical Research Council [G0701484]
- British Autism Study of Infant Siblings (BASIS) funding consortium
- COST Action [BM1004]
- NIHR Biomedical Research Centre in Mental Health at the South London
- Maudsley Foundation Trust
- Institute of Psychiatry, King's College London
- MRC [G0701484, G0500870] Funding Source: UKRI
- Medical Research Council [G0701484, G0500870, G9817803B] Funding Source: researchfish
- National Institute for Health Research [NF-SI-0510-10268] Funding Source: researchfish
Ask authors/readers for more resources
There is widespread hope that the discovery of valid biomarkers for autism will both reveal the causes of autism and enable earlier and more targeted methods for diagnosis and intervention. However, growing enthusiasm about recent advances in this area of autism research needs to be tempered by an awareness of the major scientific challenges and the important social and ethical concerns arising from the development of biomarkers and their clinical application. Collaborative approaches involving scientists and other stakeholders must combine the search for valid, clinically useful autism biomarkers with efforts to ensure that individuals with autism and their families are treated with respect and understanding.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available